DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Elmiron (Pentosan Polysulfate) - Incorrect Dose Administered - Suspected Cause - Side Effect Reports

 
 



Index of reports > Cases with Incorrect Dose Administered (10)

Below is the selection of side effect reports (a.k.a. adverse event reports) related to Elmiron (Pentosan Polysulfate) where reactions include incorrect dose administered. The selected reports were submitted to the FDA during the sample period of about a year.

Possible Elmiron side effects in female

Reported by a consumer/non-health professional from United States on 2012-05-02

Patient: female, weighing 56.7 kg (124.7 pounds)

Reactions: Hysterectomy, Incorrect Dose Administered, Adverse Event, Headache, Treatment Noncompliance, Sinusitis

Drug(s) suspected as cause:
Elmiron

Other drugs received by patient: Hydrocodone; Levofloxacin; Nasonex; Cymbalta; Tramadol HCL



Possible Elmiron side effects in female

Reported by a consumer/non-health professional from United States on 2012-04-23

Patient: female, weighing 77.1 kg (169.6 pounds)

Reactions: Gingivitis, Tinnitus, Dysphagia, Rash Papular, Incorrect Dose Administered, Dysgeusia, Dysphonia, Oral Pain, DRY Mouth, Gastrooesophageal Reflux Disease

Drug(s) suspected as cause:
Elmiron
    Administration route: Oral
    Indication: Cystitis Interstitial
    Start date: 2011-01-01
    End date: 2011-01-01

Elmiron
    Dosage: 2 100mg capsules in the night
    Administration route: Oral
    Start date: 2011-01-01

Risperdal
    Dosage: 1/2 of 0.25mg tablet
    Administration route: Oral
    End date: 2012-01-01

Risperdal
    Administration route: Oral
    Start date: 2011-01-01

Protonix

Protonix
    End date: 2011-12-23

Elmiron
    Administration route: Oral
    Start date: 2011-10-21

Elmiron
    Dosage: 2 100mg capsules in the night
    Administration route: Oral
    Start date: 2011-01-01

Protonix
    Indication: Gastric Disorder

Elmiron
    Administration route: Oral
    Start date: 2011-01-01
    End date: 2011-01-01

Risperdal
    Administration route: Oral
    Start date: 2011-06-28

Elmiron
    Administration route: Oral
    Start date: 2011-10-12

Elmiron
    Administration route: Oral
    Start date: 2011-10-21

Elmiron
    Administration route: Oral
    Indication: Bladder Pain
    Start date: 2011-10-12

Risperdal
    Dosage: 1/4 of 0.25mg tablet
    Administration route: Oral
    Indication: Anxiety

Elmiron
    Dosage: 100mg capsule in the morning
    Administration route: Oral
    Start date: 2011-01-01

Elmiron
    Dosage: 100mg capsule in the morning
    Administration route: Oral
    Start date: 2011-01-01

Protonix
    Indication: Gastrooesophageal Reflux Disease
    End date: 2011-12-23

Other drugs received by patient: Atenolol; Tenormin; Prilosec; Estradiol; Valium; Valium; Valium; Pepcid



Possible Elmiron side effects in female

Reported by a consumer/non-health professional from United States on 2012-04-02

Patient: female, weighing 77.1 kg (169.6 pounds)

Reactions: Tinnitus, Dysphagia, Gingivitis, Incorrect Dose Administered, Rash Papular, Dysgeusia, Oral Pain, Dysphonia, DRY Mouth, Gastrooesophageal Reflux Disease

Drug(s) suspected as cause:
Risperdal
    Administration route: Oral
    Start date: 2011-01-01

Risperdal
    Dosage: 1/2 of 0.25mg tablet
    Administration route: Oral
    End date: 2012-01-01

Elmiron
    Administration route: Oral
    Start date: 2011-10-12

Elmiron
    Administration route: Oral
    Indication: Cystitis Interstitial
    Start date: 2011-10-21

Elmiron
    Dosage: 100mg capsule in the morning
    Administration route: Oral
    Start date: 2011-01-01

Risperdal
    Administration route: Oral
    Indication: Anxiety
    Start date: 2011-06-28

Elmiron
    Administration route: Oral
    Indication: Bladder Pain
    Start date: 2011-10-21

Protonix
    Indication: Gastric Disorder
    End date: 2011-12-23

Elmiron
    Administration route: Oral
    Start date: 2011-01-01
    End date: 2011-01-01

Protonix

Elmiron
    Dosage: 2 100mg capsules in the night
    Administration route: Oral
    Start date: 2011-01-01

Elmiron
    Administration route: Oral
    Start date: 2011-01-01
    End date: 2011-01-01

Elmiron
    Administration route: Oral
    Start date: 2011-10-12

Risperdal
    Dosage: 1/4 of 0.25mg tablet
    Administration route: Oral

Protonix
    End date: 2011-12-23

Elmiron
    Dosage: 100mg capsule in the morning
    Administration route: Oral
    Start date: 2011-01-01

Elmiron
    Dosage: 2 100mg capsules in the night
    Administration route: Oral
    Start date: 2011-01-01

Protonix
    Indication: Gastrooesophageal Reflux Disease

Other drugs received by patient: Atenolol; Valium; Estradiol; Tenormin; Valium; Valium; Prilosec; Pepcid



Possible Elmiron side effects in female

Reported by a consumer/non-health professional from United States on 2012-03-13

Patient: female, weighing 76.7 kg (168.7 pounds)

Reactions: Tinnitus, Gingivitis, Rash Papular, Incorrect Dose Administered, Dysgeusia, Dysphonia, Oral Pain, DRY Mouth, Gastrooesophageal Reflux Disease

Drug(s) suspected as cause:
Elmiron
    Administration route: Oral
    Start date: 2011-01-01
    End date: 2011-01-01

Risperdal
    Administration route: Oral
    Start date: 2011-06-28

Risperdal
    Dosage: 1/4 of 0.25mg tablet
    Administration route: Oral
    Indication: Anxiety

Elmiron
    Dosage: 2 100mg capsules in the night
    Administration route: Oral
    Start date: 2011-01-01

Risperdal
    Administration route: Oral
    Start date: 2011-01-01

Protonix
    Indication: Gastrooesophageal Reflux Disease
    End date: 2011-12-23

Elmiron
    Administration route: Oral
    Start date: 2011-10-21

Elmiron
    Administration route: Oral

Elmiron
    Administration route: Oral

Elmiron
    Administration route: Oral
    Start date: 2011-10-21

Risperdal
    Dosage: 1/2 of 0.25mg tablet
    Administration route: Oral
    End date: 2012-01-01

Protonix

Protonix
    End date: 2011-12-23

Elmiron
    Dosage: 2 100mg capsules in the night
    Administration route: Oral
    Indication: Bladder Pain
    Start date: 2011-01-01

Elmiron
    Dosage: 100mg capsule in the morning
    Administration route: Oral
    Start date: 2011-01-01

Elmiron
    Dosage: 100mg capsule in the morning
    Administration route: Oral
    Indication: Cystitis Interstitial
    Start date: 2011-01-01

Elmiron
    Administration route: Oral
    Start date: 2011-01-01
    End date: 2011-01-01

Protonix
    Indication: Gastric Disorder

Other drugs received by patient: Valium; Valium; Valium; Atenolol



Possible Elmiron side effects in female

Reported by a consumer/non-health professional from United States on 2012-02-27

Patient: female, weighing 76.2 kg (167.6 pounds)

Reactions: Dysgeusia, Tinnitus, Oral Pain, Dysphonia, DRY Mouth, Incorrect Dose Administered, Gastrooesophageal Reflux Disease

Drug(s) suspected as cause:
Elmiron
    Administration route: Oral

Protonix
    End date: 2011-12-23

Risperdal
    Dosage: 1/2 of 0.25mg tablet
    Administration route: Oral
    Indication: Anxiety
    End date: 2012-01-01

Elmiron
    Dosage: 2 100mg capsules in the night
    Administration route: Oral
    Start date: 2011-01-01

Protonix
    Indication: Gastric Disorder

Elmiron
    Administration route: Oral
    Start date: 2011-01-01
    End date: 2011-01-01

Elmiron
    Dosage: 100mg capsule in the morning
    Administration route: Oral
    Indication: Cystitis Interstitial
    Start date: 2011-01-01

Risperdal
    Dosage: 1/4 of 0.25mg tablet
    Administration route: Oral

Risperdal
    Administration route: Oral
    Start date: 2011-01-01

Protonix
    Indication: Gastrooesophageal Reflux Disease

Protonix
    End date: 2011-12-23

Other drugs received by patient: Valium; Valium; Atenolol; Valium



Possible Elmiron side effects in female

Reported by a consumer/non-health professional from United States on 2012-02-07

Patient: female, weighing 76.2 kg (167.6 pounds)

Reactions: Dysgeusia, Tinnitus, Dysphonia, Oral Pain, Incorrect Dose Administered, DRY Mouth, Gastrooesophageal Reflux Disease

Drug(s) suspected as cause:
Protonix
    Indication: Gastric Disorder

Protonix
    End date: 2011-12-23

Elmiron
    Administration route: Oral
    Start date: 2011-01-01
    End date: 2011-01-01

Risperdal
    Dosage: 1/2 of 0.25mg tablet
    Administration route: Oral
    Indication: Anxiety
    End date: 2012-01-01

Risperdal
    Dosage: 1/4 of 0.25mg tablet
    Administration route: Oral

Protonix
    Indication: Gastrooesophageal Reflux Disease

Elmiron
    Administration route: Oral

Protonix
    End date: 2011-12-23

Elmiron
    Dosage: 2 100mg capsules in the night
    Administration route: Oral
    Start date: 2011-01-01

Risperdal
    Administration route: Oral
    Start date: 2011-01-01

Elmiron
    Dosage: 100mg capsule in the morning
    Administration route: Oral
    Indication: Cystitis Interstitial
    Start date: 2011-01-01

Other drugs received by patient: Valium; Atenolol; Valium; Valium



Possible Elmiron side effects in female

Reported by a consumer/non-health professional from United States on 2012-01-31

Patient: female, weighing 76.2 kg (167.6 pounds)

Reactions: Dysgeusia, Tinnitus, Oral Pain, Dysphonia, Incorrect Dose Administered, DRY Mouth, Gastrooesophageal Reflux Disease

Drug(s) suspected as cause:
Elmiron
    Administration route: Oral
    Start date: 2011-01-01
    End date: 2011-01-01

Elmiron
    Dosage: 2 100mg capsules in the night
    Administration route: Oral
    Start date: 2011-01-01

Protonix
    End date: 2011-12-23

Elmiron
    Administration route: Oral

Risperdal
    Dosage: 1/2 of 0.25mg tablet
    Administration route: Oral
    Indication: Anxiety
    End date: 2012-01-01

Risperdal
    Dosage: 1/4 of 0.25mg tablet
    Administration route: Oral

Protonix
    End date: 2011-12-23

Protonix
    Indication: Gastric Disorder

Elmiron
    Dosage: 100mg capsule in the morning
    Administration route: Oral
    Indication: Cystitis Interstitial
    Start date: 2011-01-01

Risperdal
    Administration route: Oral
    Start date: 2011-01-01

Protonix
    Indication: Gastrooesophageal Reflux Disease

Other drugs received by patient: Valium; Valium; Valium; Atenolol



Possible Elmiron side effects in female

Reported by a consumer/non-health professional from United States on 2012-01-13

Patient: female, weighing 76.2 kg (167.6 pounds)

Reactions: Dysgeusia, Tinnitus, Dysphonia, Incorrect Dose Administered

Drug(s) suspected as cause:
Elmiron
    Administration route: Oral
    Indication: Cystitis Interstitial

Protonix
    Indication: Gastric Disorder
    End date: 2011-12-23

Elmiron
    Administration route: Oral
    Start date: 2011-01-01
    End date: 2011-01-01

Other drugs received by patient: Valium; Atenolol; Risperidone; Valium



Possible Elmiron side effects in female

Reported by a consumer/non-health professional from United States on 2011-11-18

Patient: female, weighing 59.0 kg (129.7 pounds)

Reactions: Tinnitus, Incorrect Dose Administered, Vaginal Infection, Intentional Drug Misuse, Micturition Urgency, Gastric Disorder

Drug(s) suspected as cause:
Elmiron
    Administration route: Oral
    Indication: Cystitis Interstitial
    Start date: 2010-12-01
    End date: 2011-06-01

Elmiron
    Administration route: Oral
    Start date: 2011-06-01

Other drugs received by patient: Synthroid; Nexium; Hydrodiuril



Possible Elmiron side effects in female

Reported by a consumer/non-health professional from United States on 2011-10-11

Patient: female, weighing 87.1 kg (191.6 pounds)

Reactions: Intraocular Pressure Increased, Incorrect Dose Administered

Drug(s) suspected as cause:
Elmiron
    Administration route: Oral
    Indication: Cystitis Interstitial
    Start date: 2011-07-01

Oxybutynin
    Administration route: Oral
    Indication: Cystitis Interstitial
    Start date: 2004-01-01
    End date: 2011-07-01

Other drugs received by patient: Timolol Maleate

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017